<DOC>
	<DOCNO>NCT00136890</DOCNO>
	<brief_summary>Lung cancer remain leading cause cancer death men woman . Although overall survival remain poor , early stage non-small cell lung cancer ( NSCLC ) potentially curable . Improved stag lead stage-specific therapy patient early stage NSCLC potential candidate surgical resection , advanced disease spar morbidity risk mortality thoracotomy pulmonary resection . Despite contemporary stag technique , 25-50 % patient appear limited disease amenable surgical resection go die metastatic lung cancer . If occult micro-metastatic disease become evident later could detect reliably pre-operative assessment , patient harbor disease could spar non-curative thoracotomy . PET image potential detect mediastinal extrathoracic metastatic disease detect conventional imaging modality . This prospective , multicenter trial enroll patient biopsy-proven clinical stage I-IIIA NSCLC consider candidate surgical resection curative intent . Preoperatively , patient randomize conventional staging metastatic disease ( CT liver/adrenals , total body bone scan , CT contrast MRI gadolinium brain ) versus whole body PET PET-CT brain CT MRI contrast/gadolinium .</brief_summary>
	<brief_title>PET Imaging Potentially Surgically Resectable Non-small Cell Lung Cancers</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Histological cytological proof NSCLC Stage I , II , IIIA NSCLC base upon clinical stag The primary lesion appear technically appropriate surgical resection , base information chest xray ( CXR ) CT thorax . Age 18 year Poor pulmonary function preclude radical surgery ( inadequate pulmonary reserve radical surgery ) predict postresection forced expiratory volume 1 second ( FEV1 ) &lt; 0.8 liter &lt; 40 % predict , diffuse capacity lung carbon monoxide ( DLCO ) &lt; 40 % predicted Poor performance status ( Eastern Cooperative Oncology Group [ ECOG ] 34 ) Significant concurrent medical problem ( e.g . uncontrolled diabetes , active cardiac problem , significant chronic obstructive pulmonary disease ) make patient unfit surgery Pregnant lactating female Unable lie supine image PET Patients previously treat cancer nonmelanotic skin cancer carcinoma situ cervix , unless diseasefree 5 year great Patients , time initial evaluation , already undergone whole body PET/PETCT , CT brain , MRI brain , total body bone scan mediastinoscopy within 8 week prior randomization exclude . However , patient CT scan thorax abdomen exclude . Failure provide informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Positron-Emission Tomography</keyword>
	<keyword>PET Scan</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Thoracic Surgery</keyword>
	<keyword>Diagnostic</keyword>
	<keyword>Randomized Controlled Trial</keyword>
	<keyword>Oncology</keyword>
</DOC>